US FDA Faces Down Complex Combo Products, Fires Up Oncology Center Of Excellence

FDA officials discuss difficulties dealing with complex combination products, the future of the agency's product centers, and promotion of industry collaboration at the Drug Information Association's annual meeting.

FDA Forum Panel
FDA officials chat at the DIA meeting in Chicago • Source: Brenda Sandburg

More from Combination Products

More from Device Area